Update on Research and Treatment of Premenstrual Dysphoric Disorder
Tóm tắt
Từ khóa
Tài liệu tham khảo
Borenstein, 2005, Estimating direct and indirect costs of premenstrual syndrome., J Occup Environ Med, 47, 26, 10.1097/01.jom.0000150209.44312.d1
Deuster, 1999, Biological, social, and behavioral factors associated with premenstrual syndrome., Arch Fam Med, 8, 122, 10.1001/archfami.8.2.122
Johnson, 1988, Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior., J Reprod Med, 33, 340
Meaden, 2005, Timing and severity of symptoms associated with the menstrual cycle in a community-based sample in the Midwestern United States., Psychiatry Res, 134, 27, 10.1016/j.psychres.2005.01.003
Wood, 1979, Menstrual characteristics of 2343 women attending the Shepherd Foundation., Aust N Z J Obstet Gynaecol, 19, 107, 10.1111/j.1479-828X.1979.tb01366.x
Angst, 2001, The epidemiology of perimenstrual psychological symptoms., Acta Psychiatr Scand, 104, 110, 10.1034/j.1600-0447.2001.00412.x
Borenstein, 2007, E, Dean B B, Leifke E, Korner P, Yonkers K A. Differences in symptom scores and health outcomes in premenstrual syndrome., J Womens Health, 16, 1139, 10.1089/jwh.2006.0230
Yang, 2008, Burden of premenstrual dysphoric disorder on health-related quality of life., J Womens Health, 17, 113, 10.1089/jwh.2007.0417
Hylan, 1999, The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France., J Womens Health Gend Based Med, 8, 1043, 10.1089/jwh.1.1999.8.1043
Pearlstein, 2000, Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo., J Clin Psychiatry, 61, 101, 10.4088/JCP.v61n0205
Borenstein, 2003, Health and economic impact of the premenstrual syndrome., J Reprod Med, 48, 515
Campbell E M, Peterkin, 1997, Premenstrual symptoms in general practice patients. Prevalence and treatment., J Reprod Med, 42, 637
Wittchen H U, Becker, 2002, Prevalence, incidence and stability of premenstrual dysphoric disorder in the community., Psychol Med, 32, 119, 10.1017/S0033291701004925
Chaturvedi, 1995, K, Chandra P S, Gururaj G, Pandian R D, Beena M B. Suicidal ideas during premenstrual phase., J Affect Disord, 34, 193, 10.1016/0165-0327(95)00017-H
Stout, 1986, L, Steege J F, Blazer D G, George L K. Comparison of lifetime psychiatric diagnoses in premenstrual syndrome clinic and community samples., J Nerv Ment Dis, 174, 517, 10.1097/00005053-198609000-00002
Halbreich, 2003, The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMSPMDD)., Psychoneuroendocrinology, 28, 1
Halbreich, 2007, Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies., Gynecol Endocrinol, 23, 123, 10.1080/09513590601167969
Hurt, 1992, W, Schnurr P P, Severino S K, et al. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints., J Am Psychiatry, 149, 525, 10.1176/ajp.149.4.525
Di Giulio, 2006, D. Premenstrual dysphoric disorder: prevalence, diagnostic considerations, and controversies., J Psychosom Obstet Gynaecol, 27, 201, 10.1080/01674820600747269
2001, ACOG Practice Bulletin. Premenstrual syndrome. Number 15, April 2000., Int J Gynaecol Obstet, 73, 183
Ross L E, Steiner, 2003, A biopsychosocial approach to premenstrual dysphoric disorder., Psychiatr Clin North Am, 26, 529, 10.1016/S0193-953X(03)00035-2
Perkonigg, 2004, Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder., J Clin Psychiatry, 65, 1314, 10.4088/JCP.v65n1004
Girdler, 2004, S, Thompson K S, Light K C, Leserman J, Pedersen C A, Prange A J, Jr. Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder., Psychosom Med, 66, 403
Girdler S S, Klatzkin, 2007, Neurosteroids in the context of stress: implications for depressive disorders., Pharmacol Ther, 116, 125, 10.1016/j.pharmthera.2007.05.006
Bunevicius, 2005, L, Light K C, Leserman J, Pedersen C A, Girdler S S. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder., Biol Psychol, 69, 281, 10.1016/j.biopsycho.2004.08.002
Koci, 2007, Relationship of adolescent physical and sexual abuse to perimenstrual symptoms (PMS) in adulthood., Issues Ment Health Nurs, 28, 75, 10.1080/01612840600996281
Endicott, 2006, Daily Record of Severity of Problems (DRSP): reliability and validity., Arch Womens Ment Health, 9, 41, 10.1007/s00737-005-0103-y
Borenstein, 2007, E, Dean B B, Yonkers K A, Endicott J. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome., Obstet Gynecol, 109, 1068, 10.1097/01.AOG.0000259920.73000.3b
Mortola, 1990, F, Girton L, Beck L, Yen S S. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences., Obstet Gynecol, 76, 302
1968, The development of a menstrual distress questionnaire., Psychosom Med, 30, 853, 10.1097/00006842-196811000-00006
Endicott, 1982, Retrospective report of premenstrual depressive changes., Psychopharmacol Bull, 18, 109
Reid, 1985, Premenstrual syndrome., Curr Probl Obstet Gynecol Fertil, 8, 1
Yonkers, 2008, A, OBrien P MS, Eriksson E. Premenstrual syndrome., Lancet, 371, 1200, 10.1016/S0140-6736(08)60527-9
Woods, 1982, Prevalence of perimenstrual symptoms., J Am Public Health, 72, 1257, 10.2105/AJPH.72.11.1257
Andersch, 1986, Premenstrual complaints. Prevalence of premenstrual symptoms in a Swedish urban population., J Psychosom Obstet Gynaecol, 5, 39, 10.3109/01674828609016741
Ramcharan, 1992, J, Fick G H, Goldfien A. The epidemiology of premenstrual symptoms in a population based sample of 2650 urban women: attributable risk and risk factors., J Clin Epidemiol, 45, 377, 10.1016/0895-4356(92)90039-P
Rivera-Tovar A D, Frank, 1990, Late luteal phase dysphoric disorder in young women., J Am Psychiatry, 147, 1634, 10.1176/ajp.147.12.1634
Soares, 2001, N, Cohen L S, Otto M W, Harlow B L. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles., J Womens Health Gend Based Med, 10, 873, 10.1089/152460901753285778
Takeda, 2006, Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women., Arch Womens Ment Health, 9, 209, 10.1007/s00737-006-0137-9
Pearlstein, 2005, Pretreatment pattern of symptom expression in premenstrual dsyphoric disorder., J Affect Disord, 85, 275, 10.1016/j.jad.2004.10.004
Sternfeld, 2002, Severity of premenstrual symptoms in a health maintenance organization population., Obstet Gynecol, 99, 1014
Bloch, 1997, Premenstrual syndrome: evidence for symptom stability across cycles., J Am Psychiatry, 154, 1741, 10.1176/ajp.154.12.1741
Kendler, 1998, Longitudinal population-based study of retrospectively reported premenstrual symptoms and lifetime major depression., J Am Psychiatry, 155, 1234, 10.1176/ajp.155.9.1234
Treloar, 2002, M, Martin N G. Genetic and environmental influences on premenstrual symptoms in an Australian twin sample., Psychol Med, 32, 25, 10.1017/S0033291701004901
Dhingra, 2007, L, OBrien P M, Chapman G, Fryer A A, Ismail K M. Serotonin receptor 1A C(-1019)G polymorphism associated with premenstrual dysphoric disorder., Obstet Gynecol, 110, 788, 10.1097/01.AOG.0000284448.73490.ac
Huo, 2007, Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene., Biol Psychiatry, 62, 925, 10.1016/j.biopsych.2006.12.019
Masho S W, Adera, 2005, Obesity as a risk factor for premenstrual syndrome., J Psychosom Obstet Gynaecol, 26, 33, 10.1080/01443610400023049
Nakamoto, 2007, Impaired reactivity to mental stress in premenstrual dysphoric disorder PMDD patients., Neurosci Res, 58, S165, 10.1016/j.neures.2007.06.689
Girdler, 2007, S, Leserman J, Bunevicius R, Klatzkin R, Pedersen C A, Light K C. Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder., Health Psychol, 26, 201, 10.1037/0278-6133.26.2.201
Rosseinsky, 1974, P. An evolutionary theory of premenstrual tension., Lancet, 2, 1024, 10.1016/S0140-6736(74)92132-1
Castellanos, 1973, Aggressive behaviour in oestrus and dioestrus dairy cows and heifers., J Reprod Fertil, 34, 509
Floody, 1977, Aggressive behaviour in female hamsters: the hormonal basis for fluctuations in female aggressiveness correlated with estrous state., J Comp Physiol Psychol, 91, 443, 10.1037/h0077341
Garcia-Castell, 1989, Changes in the social dynamics associated to the menstrual cycle in the vervet monkey., Bol Estud Med Biol, 37, 11
Rapkin, 1995, Menstrual cycle and social behavior in vervet monkeys., Psychoneuroendocrinology, 20, 289, 10.1016/0306-4530(94)00060-N
Ho, 2001, The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability., Neuropsychopharmacology, 24, 502, 10.1016/S0893-133X(00)00219-0
Hyde, 1977, Estrous cycle fluctuations in aggressiveness of house mice., Horm Behav, 9, 290, 10.1016/0018-506X(77)90064-2
Schneider, 2007, Increased depressive-like traits in an animal model of premenstrual irritability., Horm Behav, 51, 142, 10.1016/j.yhbeh.2006.09.006
Marvan, 1996, Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle., Arch Med Res, 27, 83
2007, Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility., Pharmacol Biochem Behav, 87, 412, 10.1016/j.pbb.2007.05.017
MacDonald, 1991, Recurrent secretion of progesterone in large amounts: an endocrinemetabolic disorder unique to young women., Endocr Rev, 12, 372, 10.1210/edrv-12-4-372
Frank, 1931, The hormonal causes of premenstrual tension., Arch Neurol Psychiatry, 26, 1053, 10.1001/archneurpsyc.1931.02230110151009
Hammarback, 1991, Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome., Acta Endocrinol (Copenh), 125, 132, 10.1530/acta.0.1250132
Casper, 1990, The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome., J Am Obstet Gynecol, 162, 105, 10.1016/0002-9378(90)90831-Q
Casson, 1990, Lasting response to ovariectomy in severe intractable premenstrual syndrome., J Am Obstet Gynecol, 162, 99, 10.1016/0002-9378(90)90830-Z
Studd, 1994, Estrogens and depression in women., Menopause, 1, 33
Cronje, 2004, H, Vashisht A, Studd J WW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome., Hum Reprod, 19, 2152, 10.1093/humrep/deh354
Muse, 1984, The premenstrual syndrome: effects of medical ovariectomy.., N J Engl Med, 311, 1345, 10.1056/NEJM198411223112104
Bancroft, 1987, The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes., Clin Endocrinol (Oxf), 27, 171, 10.1111/j.1365-2265.1987.tb01142.x
Hammarback, 1988, Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo., Acta Obstet Gynecol Scand, 67, 159, 10.3109/00016348809004191
Sundstrom, 1999, Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen., Acta Obstet Gynecol Scand, 78, 891
Wyatt, 2004, The effectiveness of GnRHa with and without add-back therapy in treating premenstrual syndrome: a meta analysis., BJOG, 6, 585, 10.1111/j.1471-0528.2004.00135.x
Birzniece, 2006, Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems., Brain Res Rev, 51, 212, 10.1016/j.brainresrev.2005.11.001
Smith, 1998, GABA A receptor alpha-4 subunit suppression prevents withdrawal properties of an endogenous steroid., Nature, 392, 926, 10.1038/31948
Smith, 2006, Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha, 5beta-THP: a possible model of premenstrual dysphoric disorder., Psychopharmacology (Berl), 186, 323, 10.1007/s00213-005-0168-3
Sundstrom Poromaa, 2003, GABA receptors, progesterone and premenstrual dysphoric disorder., Arch Womens Ment Health, 6, 23, 10.1007/s00737-002-0147-1
Griffiths, 2005, Withdrawal from progesterone increases expression of alpha4, beta1, and delta GABA(A) receptor subunits in neurons in the periaqueductal gray matter in female Wistar rats., J Comp Neurol, 486, 89, 10.1002/cne.20540
Backstrom, 2003, Pathogenesis in menstrual cycle-linked CNS disorders., N Ann Y Acad Sci, 1007, 42, 10.1196/annals.1286.005
Schmidt, 1998, Differential behavioral effects of gonadal steriods in women with and in those without premenstrual syndrome., N J Engl Med, 338, 209, 10.1056/NEJM199801223380401
Wyatt, 2001, Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review., BMJ, 323, 776, 10.1136/bmj.323.7316.776
van Wingen, 2008, Progesterone selectively increases amygdala reactivity in women., Mol Psychiatry, 13, 325, 10.1038/sj.mp.4002030
Magos, 1986, The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome., J Br Obstet Gynaecol, 93, 1290, 10.1111/j.1471-0528.1986.tb07868.x
Hammarback, 1985, Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy., Acta Obstet Gynecol Scand, 64, 393, 10.3109/00016348509155154
Genazzani A R, Petraglia, 1998, Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences., J Clin Endocrinol Metab, 83, 2099, 10.1210/jcem.83.6.4905
Bicikova, 1998, Allopregnanolone in women with premenstrual syndrome., Horm Metab Res, 30, 227, 10.1055/s-2007-978871
Rapkin, 1997, Progesterone metabolite allopregnanolone in women with premenstrual syndrome., Obstet Gynecol, 90, 709, 10.1016/S0029-7844(97)00417-1
Schmidt, 1994, Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects., J Clin Endocrinol Metab, 79, 1256
Sundstrom, 1997, Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study., Psychoneuroendocrinology, 22, 25, 10.1016/S0306-4530(96)00035-2
Kaura, 2007, D, Gartside S E, Young A H, Judge S J. The progesterone metabolite allopregnanolone potentiates GABA(A) receptor-mediated inhibition of 5-HT neuronal activity., Eur Neuropsychopharmacol, 17, 108, 10.1016/j.euroneuro.2006.02.006
Matsumoto, 2007, GABA(A) receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders., Stress, 10, 3, 10.1080/10253890701200997
Thys-Jacobs, 2008, Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder., J Clin Endocrinol Metab, 93, 96, 10.1210/jc.2007-1726
Schmidt, 1991, Lack of effect of induced menses on symptoms in women with premenstrual syndrome., N J Engl Med, 324, 1174, 10.1056/NEJM199104253241705
Schmidt, 2005, Depression, the perimenopause, and estrogen therapy., N Ann Y Acad Sci, 1052, 27, 10.1196/annals.1347.003
Bjorn, 2003, Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy., J Clin Endocrinol Metab, 88, 2026, 10.1210/jc.2002-020755
Schmidt, 1993, Thyroid function in women with premenstrual syndrome., J Clin Endocrinol Metab, 76, 671
Girdler, 1995, Thyroid axis function during the menstral cycle in women with premenstrual syndrome., Psychoneuroendocrinology, 20, 395, 10.1016/0306-4530(94)00068-9
Korzekwa, 1996, I, Lamont J A, Steiner M. Late luteal phase dysphoric disorder and the thyroid axis revisited., J Clin Endocrinol Metab, 81, 2280
Portella, 2006, T, Haaga D A, Rohan K J. The association between seasonal and premenstrual symptoms is continuous and is not fully accounted for by depressive symptoms., J Nerv Ment Dis, 194, 833, 10.1097/01.nmd.0000244488.17025.0e
Dalgleish, 1996, Rhythm and blues: the theory and treatment of seasonal affective disorder., J Br Clin Psychol, 35, 163, 10.1111/j.2044-8260.1996.tb01174.x
Parry, 1990, L, Berga S L, Kripke D F, et al. Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression., Arch Gen Psychiatry, 47, 1139, 10.1001/archpsyc.1990.01810240059010
Pehrsson, 2007, Stable serum levels of relaxin throughout the menstrual cycle: a preliminary comparison of women with premenstrual dysphoria and controls., Arch Womens Ment Health, 10, 147, 10.1007/s00737-007-0186-8
Thys-Jacobs, 2007, Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder., J Clin Endocrinol Metab, 92, 2952, 10.1210/jc.2006-2726
Thys-Jacobs, 2008, Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder., J Am Obstet Gynecol, 198, 506, 10.1016/j.ajog.2007.11.005
Sherwood, 1986, Magnesium and the premenstrual syndrome., Ann Clin Biochem, 23, 667, 10.1177/000456328602300607
Facchinetti, 1990, Reduction of monocytes magnesium in patients affected by premenstrual syndrome., J Psychosom Obstet Gynaecol, 11, 221, 10.3109/01674829009084417
Rosenstein, 1994, Magnesium measures across the menstrual cycle in premenstrual syndrome., Biol Psychiatry, 35, 557, 10.1016/0006-3223(94)90103-1
Steiner, 2000, Premenstrual dysphoria and the serotonin system: pathophysiology and treatment., J Clin Psychiatry, 61, 17
Lesch, 1996, Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region., Science, 274, 1527, 10.1126/science.274.5292.1527
Hariri, 2002, Serotonin transporter genetic variation and the response of the human amygdala., Science, 297, 400, 10.1126/science.1071829
Parsey, 2006, Lower serotonin transporter binding potential in the human brain during major depressive episodes., J Am Psychiatry, 163, 52, 10.1176/appi.ajp.163.1.52
Eriksson, 2002, Diagnosis and treatment of premenstrual dysphoria., J Clin Psychiatry, 63, 16
Schneider, 2007, Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants., Psychoneuroendocrinology, 32, 651, 10.1016/j.psyneuen.2007.04.003
Carlsson, 1988, A regional study of sex differences in rat brain serotonin., Prog Neuropsychopharmacol Biol Psychiatry, 12, 53, 10.1016/0278-5846(88)90061-9
Hiroi, 2006, Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field., Biol Psychiatry, 60, 288, 10.1016/j.biopsych.2005.10.019
Rubinow, 1998, Estrogen-serotonin interactions: implications for affective regulation., Biol Psychiatry, 44, 839, 10.1016/S0006-3223(98)00162-0
Zhang, 1999, Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone., Neuroscience, 94, 251, 10.1016/S0306-4522(99)00234-1
Bethea, 2002, Diverse actions of ovarian steroids in the serotonin neural system., Front Neuroendocrinol, 23, 41, 10.1006/frne.2001.0225
Qiao, 2007, Isolating with physical restraint low status female monkeys during luteal phase might make an appropriate premenstrual depression syndrome model., J Affect Disord, 102, 81, 10.1016/j.jad.2006.12.011
Brzezinski, 1990, d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression., Obstet Gynecol, 76, 296
Su, 1997, Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls., J Clin Endocrinol Metab, 82, 1220
Steinberg, 1999, A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria., Biol Psychiatry, 45, 313, 10.1016/S0006-3223(98)00005-5
Landen, 2001, Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo., Psychopharmacology (Berl), 155, 292, 10.1007/s002130100718
Menkes, 1994, B, Coates D C, Fawcett J P. Acute tryptophan depletion aggravates premenstrual syndrome., J Affect Disord, 32, 37, 10.1016/0165-0327(94)90059-0
Roca, 2002, A, Murphy D L, Rubinow D. Effects of metergoline on symptoms in women with premenstrual dysphoric disorder., J Am Psychiatry, 159, 1876, 10.1176/appi.ajp.159.11.1876
Inoue, 2007, Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests., Psychopharmacology (Berl), 190, 213, 10.1007/s00213-006-0607-9
Bancroft, 1991, Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change., Psychol Med, 21, 305, 10.1017/S0033291700020407
Eriksson, 2006, Mood changes correlate to changes in brain serotonin precursor trapping in women with premenstrual dysphoria., Psychiatry Res, 146, 107, 10.1016/j.pscychresns.2005.02.012
Fitzgerald, 1997, Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder., J Am Psychiatry, 154, 556, 10.1176/ajp.154.4.556
Halbreich, 1993, Altered serotonergic activity in women with dysphoric premenstrual syndromes., J Int Psychiatry Med, 23, 1, 10.2190/J2W0-RTGD-NYKK-FF77
Melke, 2003, Serotonin transporter gene polymorphisms and platelet 3H paroxetine binding in premenstrual dysphoria., Psychoneuroendocrinology, 28, 446, 10.1016/S0306-4530(02)00033-1
Rasgon, 2000, Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome., Fertil Steril, 73, 144, 10.1016/S0015-0282(99)00452-5
Rojansky, 1991, Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes., Gynecol Obstet Invest, 31, 146, 10.1159/000293135
Steege, 1992, F, Stout A L, Knight B S, Nemeroff C B. Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome., J Am Obstet Gynecol, 167, 168, 10.1016/S0002-9378(11)91653-6
Steiner, 1999, Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant., Psychiatry Res, 87, 107, 10.1016/S0165-1781(99)00062-1
Yatham, 1989, Serotonin receptors, buspirone, and premenstrual syndrome., Lancet, 1, 1447, 10.1016/S0140-6736(89)90149-9
Jovanovic, 2006, A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria., Psychiatry Res, 148, 185, 10.1016/j.pscychresns.2006.05.002
Epperson, 2002, Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study., Arch Gen Psychiatry, 59, 851, 10.1001/archpsyc.59.9.851
Girdler, 2001, Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder., Biol Psychiatry, 49, 788, 10.1016/S0006-3223(00)01044-1
Schmidt, 1993, Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial., Arch Gen Psychiatry, 50, 467, 10.1001/archpsyc.1993.01820180069007
Bhagwagar, 2004, Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor., J Am Psychiatry, 161, 368, 10.1176/appi.ajp.161.2.368
Soderpalm, 1991, Involvement of the GABA Abenzodiazepine chloride ionophore receptor complex in the 5,7-DHT Induced anticonflict effect., Life Sci, 49, 139, 10.1016/0024-3205(91)90027-9
Sundstrom, 1998, Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial., Psychoneuroendocrinology, 23, 73, 10.1016/S0306-4530(97)00064-4
Pinna, 2006, Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake., Psychopharmacology (Berl), 186, 362, 10.1007/s00213-005-0213-2
Griffin, 1999, Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes., Proc Natl Acad Sci U S A, 96, 13512, 10.1073/pnas.96.23.13512
Batra, 2007, Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder., Biol Psychiatry, 63, 1178, 10.1016/j.biopsych.2007.10.007
Chuong, 1994, Periovulatory beta-endorphin levels in premenstrual syndrome., Obstet Gynecol, 83, 755
Chuong, 1985, Neuropeptide levels in premenstrual syndrome., Fertil Steril, 44, 760, 10.1016/S0015-0282(16)49034-5
Giannini, 1990, Beta-endorphin decline in late luteal phase dysphoric disorder., J Int Psychiatry Med, 20, 279, 10.2190/JRQJ-XTX9-CQPF-HD70
Halbreich, 1981, Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depression., Med Hypotheses, 7, 1045, 10.1016/0306-9877(81)90100-6
Straneva, 2002, A, Maixner W, Light K C, Pedersen C A, Costello N L, Girdler S S. Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder., Health Psychol, 21, 358, 10.1037/0278-6133.21.4.358
Joffe, 2006, R, Foris J M, et al. Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls., J Clin Psychiatry, 67, 297, 10.4088/JCP.v67n0218
Young E A, Korszun, 2002, The hypothalamic-pituitary-gonadal axis in mood disorders., Endocrinol Metab Clin North Am, 31, 63, 10.1016/S0889-8529(01)00002-0
Kask, 2008, Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle., Neuropsychopharmacology, 33, 2283, 10.1038/sj.npp.1301599
Epperson, 2007, N, Pittman B, Czarkowski K A, Stiklus S, Krystal J H, Grillon C. Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder., Neuropsychopharmacology, 32, 2190, 10.1038/sj.npp.1301351
Smith, 2007, S, Shen H, Gong Q H, Zhou X. Neurosteroid regulation of GABA(A) receptors: focus on the alpha4 and delta subunits., Pharmacol Ther, 116, 58, 10.1016/j.pharmthera.2007.03.008
Gulinello, 2002, Progesterone withdrawal increases the 4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology: a comparison with female rats., Neuropharmacology, 43, 701, 10.1016/S0028-3908(02)00171-5
Rubinow, 2007, R, Smith M J, Schenkel L A, Schmidt P J, Dancer K. Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls., J Affect Disord, 104, 37, 10.1016/j.jad.2007.01.031
Protopopescu, 2008, Toward a functional neuroanatomy of premenstrual dysphoric disorder., J Affect Disord, 108, 87, 10.1016/j.jad.2007.09.015
Hsu, 2007, C, Liu C Y, Hsiao M C. A comparison of the Tridimensional Personality Questionnaire in premenstrual dysphoric disorder and major depressive disorder., Compr Psychiatry, 48, 366, 10.1016/j.comppsych.2007.02.006
Faratian, 1984, Premenstrual syndrome: weight, abdominal swelling, and perceived body image., J Am Obstet Gynecol, 150, 200, 10.1016/S0002-9378(84)80016-2
Andersch, 1978, Body water and weight in patients with premenstrual tension., J Br Obstet Gynaecol, 85, 546
Andersch, 1983, Bromocriptine and premenstrual symptoms: a survey of double blind trials., Obstet Gynecol Surv, 38, 643, 10.1097/00006254-198311000-00001
Ylostalo, 1982, Bromocriptine and norethisterone in the treatment of premenstrual syndrome., Obstet Gynecol, 59, 292
Wuttke, 2003, Chaste tree (Vitex agnus-castus)pharmacology and clinical indications., Phytomedicine, 10, 348, 10.1078/094471103322004866
OBrien, 1999, Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol., J Am Obstet Gynecol, 180, 18, 10.1016/S0002-9378(99)70142-0
Oksa, 2006, Toremifene for premenstrual mastalgia: a randomised, placebo-controlled crossover study., BJOG, 113, 713, 10.1111/j.1471-0528.2006.00943.x
OBrien, 1979, Treatment of premenstrual syndrome by spironolactone., J Br Obstet Gynaecol, 86, 142, 10.1111/j.1471-0528.1979.tb10582.x
Rosenfeld, 2008, Hormonal and volume dysregulation in women with premenstrual syndrome., Hypertension, 51, 1225, 10.1161/HYPERTENSIONAHA.107.107136
Tietjen, 2007, E, Bushnell C D, Herial N A, Utley C, White L, Hafeez F. Endometriosis is associated with prevalence of comorbid conditions in migraine., Headache, 47, 1069, 10.1111/j.1526-4610.2007.00784.x
Bancroft, 1995, Perimenstrual depression: its relationship to pain, bleeding, and previous history of depression., Psychosom Med, 57, 445, 10.1097/00006842-199509000-00006
Steiner, 2000, Diagnosis and treatment of premenstrual dysphoric disorder: an update., Int Clin Psychopharmacol, 15, S5
Kim, 2004, R, Gyulai L, Freeman E W, Morrison M F, Baldassano C, Dube B. Premenstrual dysphoric disorder and psychiatric co-morbidity., Arch Womens Ment Health, 7, 37, 10.1007/s00737-003-0027-3
Pearlstein, 1990, B, Frank E, Rivera-Tovar A, Thoft J S, Jacobs E, Mieczkowski T A. Prevalence of AxisII Axis I disorders in women with late luteal phase dysphoric disorder., J Affect Disord, 20, 129, 10.1016/0165-0327(90)90126-S
Halbreich, 1985, Relationship of dysphoric premenstrual changes to depressive disorders., Acta Psychiatr Scand, 71, 331, 10.1111/j.1600-0447.1985.tb02532.x
Endicott, 1981, Premenstrual changes and affective disorders., Psychosom Med, 43, 519, 10.1097/00006842-198112000-00008
Mackenzie T B, Wilcox, 1986, Lifetime prevalence of psychiatric disorders in women with perimenstrual difficulties., J Affect Disord, 10, 15, 10.1016/0165-0327(86)90044-3
Fava, 1992, P, Giovanni R, Genazzani A R, Facchinetti F. Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder., J Anxiety Disord, 6, 325, 10.1016/0887-6185(92)90004-Q
Critchlow, 2001, Mood disorder history and personality assessment in premenstrual dysphoric disorder., J Clin Psychiatry, 62, 688, 10.4088/JCP.v62n0905
De Ronchi, 2000, Personality disorders and depressive symptoms in late luteal phase dysphoric disorder., Psychother Psychosom, 69, 27, 10.1159/000012363
Maskall, 1997, D, Lam R W, Misri S, et al. Seasonality of symptoms in women with late luteal phase dysphoric disorder., J Am Psychiatry, 154, 1436, 10.1176/ajp.154.10.1436
Praschak-Rieder, 2001, Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder., J Affect Disord, 63, 239, 10.1016/S0165-0327(00)00176-2
Graze K K, Nee, 1990, Premenstrual depression predicts future major depressive disorder., Acta Psychiatr Scand, 81, 201, 10.1111/j.1600-0447.1990.tb06479.x
Hartlage, 2001, A, Arduino K E, Gehlert S. Premenstrual dysphoric disorder and risk for major depressive disorder: a preliminary study., J Clin Psychol, 57, 1571, 10.1002/jclp.1119
Richards, 2006, Premenstrual symptoms and perimenopausal depression., J Am Psychiatry, 163, 133, 10.1176/appi.ajp.163.1.133
Bloch, 2000, Effects of gonadal steroids in women with a history of postpartum depression., J Am Psychiatry, 157, 924, 10.1176/appi.ajp.157.6.924
2001, Premenstrual exacerbations of mood disorders., Psychopharmacol Bull, 35, 135
Joffe, 2007, F, Viguera A C, et al. Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary report., J Clin Psychiatry, 68, 1954, 10.4088/JCP.v68n1218
Harvey, 2007, T, Silkey B S, Kornstein S G, Clary C M. Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status., J Clin Psychiatry, 68, 951, 10.4088/JCP.v68n0620
Kornstein, 2005, G, Harvey A T, Rush A J, et al. Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression., Psychol Med, 35, 683, 10.1017/S0033291704004106
Yonkers K A, White, 1992, Premenstrual exacerbation of depression: one process or two., J Clin Psychiatry, 53, 289
Hardoy, 2006, C, Serra M, Carta M G, Contu P, Pisu M G, Biggio G. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder., J Clin Psychopharmacol, 26, 379, 10.1097/01.jcp.0000229483.52955.ec
Hartlage, 2004, A, Brandenburg D L, Kravitz H M. Premenstrual exacerbation of depressive disorders in a community-based sample in the United States., Psychosom Med, 66, 698, 10.1097/01.psy.0000138131.92408.b9
Hsiao, 2002, C, Liu C Y, Chen K C, Hsieh T T. Characteristics of women using a mental health clinic in a gynecologic out-patient setting., Psychiatry Clin Neurosci, 56, 459, 10.1046/j.1440-1819.2002.01036.x
Payne, 2007, L, Roy P S, Murphy-Eberenz K, et al. Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder., J Affect Disord, 99, 221, 10.1016/j.jad.2006.08.013
Landen, 2003, How does premenstrual dysphoric disorder relate to depression and anxiety disorders., Depress Anxiety, 17, 122, 10.1002/da.10089
1997, Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders., J Clin Psychiatry, 58, 62
Vulink, 2006, C, Denys D, Bus L, Westenberg H G. Female hormones affect symptom severity in obsessive-compulsive disorder., Int Clin Psychopharmacol, 21, 171, 10.1097/01.yic.0000199454.62423.99
Baker, 2007, C, Kahan T L, Trinder J, Colrain I M. Sleep quality and the sleep electroencephalogram in women with severe premenstrual syndrome., Sleep, 30, 1283, 10.1093/sleep/30.10.1283
Halbreich, 2006, M, Eriksson E, Backstrom T, Yonkers K A, Freeman E W. Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndromepremenstrual dysphoric disorder., CNS Drugs, 20, 523, 10.2165/00023210-200620070-00001
Wyatt, 2002, Selective serotonin reuptake inhibitors for premenstrual syndrome., Cochrane Database Syst Rev, CD001396
Eriksson, 1995, The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome., Neuropsychopharmacology, 12, 167, 10.1016/0893-133X(94)00076-C
Ozeren, 1997, Fluoxetine in the treatment of premenstrual syndrome., J Eur Obstet Gynecol Reprod Biol, 73, 167, 10.1016/S0301-2115(97)02741-3
Menkes, 1992, B, Taghavi E, Mason P A, Spears G FS, Howard R C. Fluoxetine treatment of severe premenstrual syndrome., Br J Med, 305, 346, 10.1136/bmj.305.6849.346
Su, 1997, Fluoxetine in the treatment of premenstrual dysphoria., Neuropsychopharmacology, 16, 346, 10.1016/S0893-133X(96)00245-X
Wood, 1992, H, Mortola J F, Chan Y F, Moossazadeh F, Yen S S. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study., Obstet Gynecol, 80, 339
Steiner, 1997, Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria., Psychopharmacol Bull, 33, 771
Sundblad, 1993, Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial., Neuropsychopharmacology, 9, 133, 10.1038/npp.1993.52
Sundblad, 1992, Clomipraine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial., Acta Psychiatr Scand, 85, 39, 10.1111/j.1600-0447.1992.tb01440.x
Wikander, 1998, Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle., J Clin Psychopharmacol, 18, 390, 10.1097/00004714-199810000-00007
Ravindran, 2007, N, Woods S A, Steiner M, Ravindran A V. Symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD): a case series., Arch Womens Ment Health, 10, 125, 10.1007/s00737-007-0181-0
Eriksson, 2008, MD, Ekman A P, Sinclair S MD, et al. Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder., J Clin Psychopharmacol, 28, 195, 10.1097/JCP.0b013e3181678a28
Pearlstein, 1997, Comparison of fluoxetine, buproprion, and placebo in the treatment of premenstrual dysphoric disorder., J Clin Psychopharmacol, 17, 261, 10.1097/00004714-199708000-00004
Steiner, 2003, Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder., Arch Womens Ment Health, 6, 71, 10.1007/s00737-002-0162-2
Stone, 1991, Fluoxetine in the treatment of late luteal phase dysphoric disorder., J Clin Psychiatry, 52, 290
Cohen, 2002, Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries., Obstet Gynecol, 100, 435
Miner, 2002, Weekly luteal phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial., Clin Ther, 24, 417, 10.1016/S0149-2918(02)85043-3
Yonkers, 1996, A, Halbreich U, Freeman E W, Brown C S, Pearlstein T B. Sertraline in the treatment of premenstrual dysphoric disorder., Psychopharmacol Bull, 32, 41
Freeman, 2000, Predictors of response to sertraline treatment of severe premenstrual syndromes., J Clin Psychiatry, 61, 579, 10.4088/JCP.v61n0807
Cohen, 2004, Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial., Psychosom Med, 66, 707, 10.1097/01.psy.0000140005.94790.9c
Steiner, 2005, Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder., J Am Obstet Gynecol, 193, 352, 10.1016/j.ajog.2005.01.021
Yonkers, 2006, Symptom-onset treatment for women with premenstrual dysphoric disorder., J Clin Psychopharmacol, 26, 198, 10.1097/01.jcp.0000203197.03829.ae
Landen, 2007, Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder., Neuropsychopharmacology, 32, 153, 10.1038/sj.npp.1301216
Freeman, 2001, Venlafaxine in the treatment of premenstrual dysphoric disorder., Obstet Gynecol, 98, 737
Cohen, 2004, Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder., J Clin Psychopharmacol, 24, 540, 10.1097/01.jcp.0000138767.53976.10
Freeman, 2004, Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder., J Am Psychiatry, 161, 343, 10.1176/appi.ajp.161.2.343
Eriksson, 2002, New perspectives on the treatment of premenstrual syndrome and premenstrual dysphoric disorder., Arch Womens Ment Health, 4, 111, 10.1007/s007370200009
Steiner, 2006, Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs., J Womens Health (Larchmt), 15, 57, 10.1089/jwh.2006.15.57
Freeman, 1999, Differential response to antidepressants in women with premenstrual syndromepremenstrual dysphonic disorder: a randomised controlled trial., Arch Gen Psychiatry, 56, 932, 10.1001/archpsyc.56.10.932
Halbreich, 2003, Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline., Expert Opin Pharmacother, 4, 2065, 10.1517/14656566.4.11.2065
Jermain, 1999, Luteal phase sertraline treatment for premenstrual dysphoric disorder: results of a double-blind, placebo-controlled, crossover study., Arch Fam Med, 8, 328, 10.1001/archfami.8.4.328
Young, 1998, Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomised, double-blind, placebo controlled crossover trial., J Clin Psychiatry, 59, 76, 10.4088/JCP.v59n0206
Yonkers, 2005, A, Pearlstein T, Fayyad R, Gillespie J A. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase., J Affect Disord, 85, 317, 10.1016/j.jad.2004.10.006
Halbreich, 1997, W. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome., J Clin Psychiatry, 58, 399, 10.4088/JCP.v58n0905
Halbreich, 2002, Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder., Obstet Gynecol, 100, 1219
Freeman, 2005, W, Sondheimer S J, Sammel M D, Ferdousi T, Lin H. A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder., J Clin Psychiatry, 66, 769, 10.4088/JCP.v66n0616
Kornstein, 2006, G, Pearlstein T B, Fayyad R, Farfel G M, Gillespie J A. Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies., J Clin Psychiatry, 67, 1624, 10.4088/JCP.v67n1020
Sundblad, 1997, A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side effects during ten cycles of treatment., Eur Neuropsychopharmacol, 7, 201, 10.1016/S0924-977X(97)00404-5
Michelson, 2000, Interruption of selective serotonin reuptake inhibitor treatment: double-blind placebo-controlled trial., J Br Psychiatry, 176, 363, 10.1192/bjp.176.4.363
Rosenbaum, 1998, Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial., Biol Psychiatry, 44, 77, 10.1016/S0006-3223(98)00126-7
Judge, 2002, Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment., Int Clin Psychopharmacol, 17, 217, 10.1097/00004850-200209000-00002
Steiner, 1980, Treatment of premenstrual tension with lithium carbonate. A pilot study., Acta Psychiatr Scand, 61, 96, 10.1111/j.1600-0447.1980.tb00569.x
Freeman, 1999, W, Rickels K, Sondheimer S J, Polansky M. Differential response to antidepressants in women with premenstrual syndromepremenstrual dysphoric disorder: a randomized controlled trial., Arch Gen Psychiatry, 56, 932, 10.1001/archpsyc.56.10.932
Rickels, 1989, Buspirone in treatment of premenstrual syndrome., Lancet, 4, 777, 10.1016/S0140-6736(89)92591-9
Smith, 1987, Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial., Obstet Gynecol, 70, 37
Harrison, 1990, Treatment of premenstrual dysphoria with alprazolam., Arch Gen Psychiatry, 47, 270, 10.1001/archpsyc.1990.01810150070011
Freeman, 1995, A double-blind trail of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome., JAMA, 274, 51, 10.1001/jama.1995.03530010065036
Usman, 2008, Hormonal management of premenstrual syndrome., Best Pract Res Clin Obstet Gynaecol, 22, 251, 10.1016/j.bpobgyn.2007.07.001
Dhar, 1990, Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS)., Psychoneuroendocrinology, 15, 489, 10.1016/0306-4530(90)90072-H
Leather, 1999, The treatment of severe premenstrual syndrome with goserelin with and without add-back estrogen therapy: a placebo-controlled study., Gynecol Endocrinol, 13, 48, 10.1080/09513599909167531
Di Carlo, 2001, Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome., Fertil Steril, 75, 380, 10.1016/S0015-0282(00)01707-6
Halbreich, 1991, Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes., Fertil Steril, 56, 1066, 10.1016/S0015-0282(16)54718-9
Deeny, 1991, Low dose danazol in the treatment of the premenstrual syndrome., Postgrad J Med, 67, 450, 10.1136/pgmj.67.787.450
Sarno, 1987, Premenstrual syndrome: beneficial effects of periodic, low-dose danazol., Obstet Gynecol, 70, 33
Day, 1979, Danazol and premenstrual syndrome., Postgrad J Med, 55, 87
Watts, 1987, A clinical trial using danazol for the treatment of premenstrual tension., J Br Obstet Gynaecol, 94, 30, 10.1111/j.1471-0528.1987.tb02248.x
Hahn, 1995, M, Van Vugt D A, Reid R L. A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome., Psychoneuroendocrinology, 20, 193, 10.1016/0306-4530(94)00053-D
Magos, 1986, Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo-controlled study., Br J Med (Clin Res Ed), 292, 1629, 10.1136/bmj.292.6536.1629
Watson, 1990, R, Studd J W, Savvas M, Baber R J. The long-term effects of estradiol implant therapy for the treatment of premenstrual syndrome., Gynecol Endocrinol, 4, 99, 10.3109/09513599009012326
Watson, 1989, Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone., Lancet, 2, 730, 10.1016/S0140-6736(89)90784-8
Domoney, 2003, Treatment of premenstrual syndrome with transdermal oestrogen., J Int Gynaecol Obstet, 83, 37
Wildemeersch, 2003, Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system., J Am Obstet Gynecol, 188, 1297, 10.1067/mob.2003.346
Bancroft, 1993, The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms., J Psychosom Res, 37, 195, 10.1016/0022-3999(93)90086-U
1992, A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive., J Psychosom Res, 36, 257, 10.1016/0022-3999(92)90090-O
Sulak, 2000, Hormone withdrawal symptoms in oral contraceptive users., Obstet Gynecol, 95, 261
Sulak, 2002, Acceptance of altering the standard 21-day7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms., J Am Obstet Gynecol, 186, 1142, 10.1067/mob.2002.122988
2002, Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder., J Eur Contracept Reprod Health Care, 7, 27
Yonkers, 2005, Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder., Obstet Gynecol, 106, 492, 10.1097/01.AOG.0000175834.77215.2e
Pearlstein, 2005, Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation., Contraception, 72, 414, 10.1016/j.contraception.2005.08.021
Rubig, 2003, Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties., Climateric, 6, 49
Eriksson, 1992, Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls., Psychoneuroendocrinology, 17, 195, 10.1016/0306-4530(92)90058-F
Krasnik, 2005, M, Guyatt G H, Heels-Ansdell D, Busse J W. The effect of bright light therapy on depression associated with premenstrual dysphoric disorder., J Am Obstet Gynecol, 193, 658, 10.1016/j.ajog.2005.01.055
Lam, 1999, W, Carter D, Misri S, Kuan A J, Yatham L N, Zis A P. A controlled study of light therapy in women with late luteal phase dysphoric disorder., Psychiatry Res, 86, 185, 10.1016/S0165-1781(99)00043-8
Parry, 1989, L, Berga S L, Mostofi N, Sependa P A, Kripke D F, Gillin J C. Morning versus evening bright light treatment of late luteal phase dysphoric disorder., J Am Psychiatry, 146, 1215, 10.1176/ajp.146.9.1215
Vellacott, 1987, A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome., Curr Med Res Opin, 10, 450, 10.1185/03007998709112403
Aslaksen, 1991, Spironolactone in the treatment of premenstrual tension: a double-blind study of spironolactone vs. bendroflumethiazide and placebo., Curr Ther Res Clin Exp, 49, 120
Wang, 1995, Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study., Acta Obstet Gynecol Scand, 74, 803, 10.3109/00016349509021201
Wyatt, 1999, M, Dimmock P W, Jones P W, Shaughn OBrien P M. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review., BMJ, 318, 1375, 10.1136/bmj.318.7195.1375
London, 1991, Effect of nutritional supplement on premenstrual symptomatology in women with premenstrual syndrome: a double-blind longitudinal study., J Am Coll Nutr, 10, 494, 10.1080/07315724.1991.10718176
Thys-Jacobs, 2000, Micronutrients and the premenstrual syndrome: the case for calcium., J Am Coll Nutr, 19, 220, 10.1080/07315724.2000.10718920
Thys-Jacobs, 1989, Calcium supplementation in premenstrual syndrome: a randomized crossover trial., J Gen Intern Med, 4, 183, 10.1007/BF02599520
Thys-Jacobs, 1998, Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group., J Am Obstet Gynecol, 179, 444, 10.1016/S0002-9378(98)70377-1
Walker, 1998, F, De Souza M C, Vickers M F, Abeyasekera S, Collins M L, Trinca L A. Magnesium supplementation alleviates premenstrual symptoms of fluid retention., J Womens Health, 7, 1157, 10.1089/jwh.1998.7.1157
Khine, 2006, L, Elin R J, Niemela J E, Schmidt P J, Rubinow D R. Magnesium (Mg) retention and mood effects after intravenous Mg infusion in premenstrual dysphoric disorder., Biol Psychiatry, 59, 327, 10.1016/j.biopsych.2005.07.022
Schellenberg, 2001, Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study., BMJ, 322, 134, 10.1136/bmj.322.7279.134
Berger, 2000, Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS)., Arch Gynecol Obstet, 264, 150, 10.1007/s004040000123
Atmaca, 2003, Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder., Hum Psychopharmacol, 18, 191, 10.1002/hup.470
Loch E G, Selle, 2000, Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus., J Womens Health Gend Based Med, 9, 315, 10.1089/152460900318515
Budeiri, 1996, Is evening primrose oil of value in the treatment of premenstrual syndrome., Control Clin Trials, 17, 60, 10.1016/0197-2456(95)00082-8
Stevinson, 2000, A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome., BJOG, 107, 870, 10.1111/j.1471-0528.2000.tb11085.x
Rossignol A M, Bonnlander, 1990, Caffeine-containing beverages, total fluid consumption, and premenstrual syndrome., J Am Public Health, 80, 1106, 10.2105/AJPH.80.9.1106
Sayegh, 1995, The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome., Obstet Gynecol, 86, 520, 10.1016/0029-7844(95)00246-N
Freeman, 2002, Treatment of premenstrual syndrome with a carbohydrate-rich beverage., J Int Gynecol Obstet, 77, 253, 10.1016/S0020-7292(02)00033-4
Steege, 1993, The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study., J Psychosom Res, 37, 127, 10.1016/0022-3999(93)90079-U
Hunter, 2002, A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder., J Psychosom Obstet Gynaecol, 23, 193, 10.3109/01674820209074672
Hunter, 2002, S, Ussher J M, Cariss M, Browne S, Jelley R, Katz M. Medical (fluoxetine) and psychological (cognitive-behavioural therapy) treatment for premenstrual dysphoric disorder: a study of treatment processes., J Psychosom Res, 53, 811, 10.1016/S0022-3999(02)00338-0
Blake, 1998, Cognitive therapy for premenstrual syndrome: a controlled trial., J Psychosom Res, 45, 307, 10.1016/S0022-3999(98)00042-7
1995, The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes., J Affect Disord, 33, 57, 10.1016/0165-0327(94)00073-I
Mira, 1986, Mefenamic acid in the treatment of premenstrual syndrome., Obstet Gynecol, 68, 395, 10.1097/00006250-198609000-00022
Facchinetti, 1989, Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study., Gynecol Obstet Invest, 28, 205, 10.1159/000293579
Chuong, 1994, Effect of naloxone on luteinizing hormone secretion in premenstrual syndrome., Fertil Steril, 61, 1039, 10.1016/S0015-0282(16)56753-3